Renato Bernardini
Overview
Explore the profile of Renato Bernardini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
1160
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Julian E, Belleman T, Garcia M, Rutten-van Molken M, Doeswijk R, Giuliani R, et al.
J Mark Access Health Policy
. 2025 Feb;
13(1):6.
PMID: 39990187
Background: We examined four potential challenges for the implementation of the European Union (EU) Regulation 2021/2282 on Health Technology Assessment (EU HTAR): interaction with the European Medicines Agency (EMA), expert...
2.
Cantone A, Burgaletto C, Di Benedetto G, Gaudio G, Giallongo C, Caltabiano R, et al.
J Neuroimmune Pharmacol
. 2025 Feb;
20(1):15.
PMID: 39918606
Alzheimer's disease (AD) is the most common cause of dementia worldwide, characterized by accumulation of amyloid-β protein and hyperphosphorylated tau protein in the brain. Neuroinflammation, resulting from chronic activation of...
3.
Cohen G, Bellanca C, Bernardini R, Rose J, Polosa R
iScience
. 2024 Dec;
27(11):111090.
PMID: 39620129
Video Abstract:
4.
Musumeci T, Di Benedetto G, Carbone C, Bonaccorso A, Amato G, Lo Faro M, et al.
Biomedicines
. 2024 Nov;
12(11).
PMID: 39595214
Figure 5 in the original publication [...].
5.
Cuocina M, Aiello G, Cutrufelli P, Rampello M, Rapisarda L, Rodolico A, et al.
Front Pharmacol
. 2024 Sep;
15:1462612.
PMID: 39309000
Background: N-acetyl cysteine (NAC) appears promising as a treatment in patients with substance use disorder (SUD) as it helps rebalance glutamate levels in the central nervous system (CNS). Basal concentrations...
6.
Julian E, Sola-Morales O, Garcia M, Brinkhuis F, Pavlovic M, Martin-Saborido C, et al.
J Mark Access Health Policy
. 2024 Jul;
12(3):128-143.
PMID: 39072306
Background: This work aimed to determine the role and action points for the involvement of medical societies in the European Health Technology Assessment (EU HTA) Methods: An online pre-convention survey...
7.
Marino A, Augello E, Stracquadanio S, Bellanca C, Cosentino F, Spampinato S, et al.
Int J Mol Sci
. 2024 Jul;
25(13).
PMID: 38999924
represents a significant concern in nosocomial settings, particularly in critically ill patients who are forced to remain in hospital for extended periods. The challenge of managing and preventing this organism...
8.
Bellanca C, Augello E, Di Benedetto G, Burgaletto C, Cantone A, Cantarella G, et al.
Front Pharmacol
. 2024 Jul;
15:1406860.
PMID: 38957391
Currently 1.3 billion individuals globally engage in smoking, leading to significant morbidity and mortality, particularly among diabetic patients. There is urgent need for a better understanding of how smoking influences...
9.
Brinkhuis F, Julian E, van den Ham H, Gianfrate F, Strammiello V, Berntgen M, et al.
Health Res Policy Syst
. 2024 Jul;
22(1):74.
PMID: 38956568
Background: The European Regulation on Health Technology Assessment (EU HTA R), effective since January 2022, aims to harmonize and improve the efficiency of common HTA across Member States (MS), with...
10.
Bracciama E, Sapuppo A, Rapisarda L, Siciliano E, Caciotti A, Morrone A, et al.
Curr Issues Mol Biol
. 2024 Jun;
46(6):6112-6120.
PMID: 38921036
Wilson's disease (WD) is a biallelic disease-causing variant in the gene on chromosome 13q14.3 that results in copper accumulation in many organs, particularly the liver and brain. The phenotypic spectrum...